Miles Gerson

Miles joined SV as a partner in 2026 and is co-leading SV Health Investors’ Dementia Discovery Fund (DDF).
Prior to joining SV, Miles served as Head of Takeda Ventures where he managed Takeda’s corporate venture team and oversaw an equity portfolio of more than 60 private and public life sciences investments. During his tenure, he was responsible for leading the corporate venture capital group’s global investment strategy, sourcing, executing and managing investments aligned with Takeda’s R&D priorities, working closely with portfolio companies at the board and strategic levels. He also served on multiple LP Advisory Committees associated with Takeda Ventures’ LP positions. Additionally, on an interim basis, he served as Takeda’s Head of GI Business Development, leading a team of licensing transactors in support of Takeda’s R&D GI unit.
Prior to Takeda Ventures, Miles served as founding management of early-stage companies, led investment diligence for venture and private equity firms based in the US and Europe and held multiple senior operational roles for venture-backed and publicly-traded life sciences companies.